226 related articles for article (PubMed ID: 12693297)
21. Interaction between warfarin and cranberry juice.
Paeng CH; Sprague M; Jackevicius CA
Clin Ther; 2007 Aug; 29(8):1730-5. PubMed ID: 17919554
[TBL] [Abstract][Full Text] [Related]
22. Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
DeVore KJ; Hobbs RA
Pharmacotherapy; 2007 Mar; 27(3):472-5. PubMed ID: 17316159
[TBL] [Abstract][Full Text] [Related]
23. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
Knudsen JF; Sokol GH
Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
[TBL] [Abstract][Full Text] [Related]
24. Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland.
Kurnik D; Loebstein R; Farfel Z; Ezra D; Halkin H; Olchovsky D
Medicine (Baltimore); 2004 Mar; 83(2):107-113. PubMed ID: 15028964
[TBL] [Abstract][Full Text] [Related]
25. [Amiodarone: treatment or cause of atrial fibrillation?].
Allali G; Falconnet C
Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735
[TBL] [Abstract][Full Text] [Related]
26. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
27. Amiodarone for atrial fibrillation.
Kurnik D; Loebstein R; Olchovsky D
N Engl J Med; 2007 Jun; 356(23):2424-6; author reply 2424-6. PubMed ID: 17561530
[No Abstract] [Full Text] [Related]
28. Insidiously evolving, occult drug interaction involving warfarin and amiodarone.
Cheung B; Lam FM; Kumana CR
BMJ; 1996 Jan; 312(7023):107-8. PubMed ID: 8555895
[No Abstract] [Full Text] [Related]
29. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
30. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
[TBL] [Abstract][Full Text] [Related]
31. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
Brown MC
Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
[TBL] [Abstract][Full Text] [Related]
32. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
33. Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis.
Perret-Guillaume C; Wahl DG
Thromb Haemost; 2004 Feb; 91(2):394-402. PubMed ID: 14961170
[TBL] [Abstract][Full Text] [Related]
34. [Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared].
Kropacheva ES; Panchenko EP; Ataullakhanova DM
Klin Med (Mosk); 2005; 83(1):24-7. PubMed ID: 15759486
[TBL] [Abstract][Full Text] [Related]
35. [Interaction between warfarin and nalidic acid].
Gulløv AL; Koefoed BG; Petersen P
Ugeskr Laeger; 1996 Sep; 158(37):5174-5. PubMed ID: 8848852
[TBL] [Abstract][Full Text] [Related]
36. Amiodarone-induced thyroid dysfunction.
Porsche R; Brenner ZR
Crit Care Nurse; 2006 Jun; 26(3):34-41; quiz 42. PubMed ID: 16717385
[No Abstract] [Full Text] [Related]
37. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model.
Miki A; Ohtani H; Sawada Y
J Clin Pharm Ther; 2011 Dec; 36(6):642-50. PubMed ID: 21143257
[TBL] [Abstract][Full Text] [Related]
38. Warfarin prevalence, indications for use and haemorrhagic events.
Ouirke W; Cahill M; Perera K; Sargent J; Conway J
Ir Med J; 2007 Mar; 100(3):402-4. PubMed ID: 17491542
[TBL] [Abstract][Full Text] [Related]
39. Chitosan potentiation of warfarin effect.
Huang SS; Sung SH; Chiang CE
Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
[TBL] [Abstract][Full Text] [Related]
40. Decreased INR response secondary to warfarin-flucloxacillin interaction.
Garg A; Mohammed M
Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
